Cleveland v. Ludwig Institute for Cancer Research Ltd.

District Court, S.D. California·Decided July 20, 2022·No. 3:21-cv-00871·Unknown

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 DON CLEVLAND, et al., Case No.: 21cv871 JM (JLB) 12 Plaintiffs, ORDER ON PARTIAL MOTION TO 13 v. DISMISS AND MOTION TO SEAL 14 LUDWIG INSTITUTE FOR CANCER RESEARCH LTD., 15 16 Defendant. 17 18 19 Presently before the court is Defendant Ludwig Institute for Cancer Research 20 Ltd. s ( Ludwig ) Partial Motion to Dismiss (Fed. R. Civ. Proc. 12(B)(6)) Plaintiffs 21 First Amended Complaint (Doc. No. 31) and Plaintiffs Motion to Seal (Doc. No. 35). 22 The motions have been fully briefed and the court finds them suitable for determination 23 on the papers submitted and without oral argument in accordance with Civil Local Rule 24 7.1(d)(1). For the reasons set forth below, the court grants-in-part and denies-in-part 25 Defendant s Partial Motion to Dismiss and denies Plaintiffs Motion to Seal. 26 /// 27 /// 28 /// I I. BACKGROUND 2 A. Procedural Background 3 On May 5, 2021, Plaintiffs Don Cleveland, Arshad Desai, Frank Furnari, Richard 4 Kolodner, Paul Mischel, Karen Oegema, and Bing Ren (“Plaintiffs’’) filed suit against 5 ||Defendant. See Doc. No. 1. (“Compl.”) Plaintiffs’ Complaint asserted six causes of 6 || action arising primarily under labor and employment laws. /d. 7 On July 6, 2021, Defendant filed a Motion to Dismiss. (Doc. No. 14). Plaintiffs 8 || filed a Response (Doc. No. 15), and Defendant subsequently filed a Reply (Doc. No. 16). 9 ||On January 7, 2022, this court denied-in-part and granted-in-part, Defendant’s motion to 10 || dismiss. 11 On March 2, 2022, Plaintiffs filed an Amended Complaint (“FAC”), again, 12 || alleging six causes of action. (Doc. No. 27.) 13 On March 31, 2022, Defendant Ludwig filed its motion for dismissal under Federal 14 || Rule of Civil Procedure 12(b)(6). (Doc. No. 31.) Plaintiffs filed a response in opposition 15 || (Doc. No. 34), and Defendant duly filed its reply (Doc. No. 37). 16 B. Factual Background! 17 The FAC alleges substantially similar allegations to that of the original complaint. 18 || The causes of action arise from Defendant’s employment of Plaintiffs at Defendant’s 19 |lresearch branch (“San Diego Branch”) at the University of California, San Diego 20 || (‘UCSD’) and Defendant’s subsequent decision to close this branch. 21 Specifically, Plaintiffs assert that: Defendant retaliated against Plaintiff Kolodner 22 ||after Kolodner disclosed his belief Defendant’s 2020-2021 budgets were allegedly 23 insufficient to meet Defendant’s various legal obligations (Count I); Defendant retaliated 24 || against all Plaintiffs after each declined to sign the Transition Agreement (Count II); age 25 ©.

27 ||! The Factual Background is derived from Plaintiffs’ FAC. In a Motion to Dismiss, □□□□□□□ allegations of material fact are taken as true and construed in the light most favorable to the nonmoving party.” Thompson v. Davis, 295 F.3d 890, 895 (9th Cir. 2002).

1 || discrimination (Count III); wrongful adverse employment action in violation of public 2 || policy (Count IV); breach of contract and penalties for failure to timely pay wages (Count 3 || V); and unfair competition (Count VI). Jd. {[§| 46-101. 4 1. Defendant’s Affiliation Agreement with UCSD 5 In 1991, Defendant entered into an Affiliation Agreement with UCSD to establish a 6 ||research branch. (Doc. No. 27 (“FAC.”) § 17). The Affiliation Agreement required 7 Defendant to appoint a Branch Director and select employees for the “continuous, active 8 ||conduct of medical research.” Jd. at J] 17, 19-20. 9 2. Plaintiffs’ Employment 10 According to the FAC, Plaintiffs are “leading scientists who have committed their 11 ||/research programs to pursuing breakthroughs in cancer prevention and control.” □□□ at 12 1. Between 1996 and 2016, Plaintiffs each accepted written employment offers from 13 ||Defendant to establish laboratories at Defendant’s San Diego Branch (“Laboratory 14 Support Agreements”). Jd. 7-13, 22. The Laboratory Support Agreements promised 15 || Plaintiffs an annual budget that would include Plaintiffs’ salaries, benefits, and funding 16 || for Plaintiffs’ research. Jd. § 22. Defendant also agreed to pay Plaintiffs at UCSD’s 17 ||salary scale. /d. § 23. In addition, Plaintiffs separately entered employment contracts 18 || with Defendant, under which Plaintiffs were appointed as Defendant’s “Members” for a 19 rolling term of five years. Id. ¥ 25. 20 Defendant’s Member-Track Appointment and Promotion Policy is applicable to each 21 || of the Plaintiffs and states that a “rolling five year appointment” is convertible to a fixed 22 only after review and recommendation by Ludwig’s Scientific Advisory Committee 23 approval by the Ludwig Board of Directors. /d. § 26. This required review process 24 || of Plaintiffs’ rolling terms of employment did not occur. Jd. 25 3. Decision to Close San Diego Branch 26 In a board meeting held In April 2018, Defendant made the decision to close the San 27 || Diego Branch by December 31, 2023. Jd. §§| 3, 30. Minutes from the meeting disclose 28 || that the Branch was viewed as “post mature.” Jd. 4 at 30. Earlier board minutes refer to

| || Plaintiffs as being “senior scientists,” noted that Plaintiffs were over the age of 64/65, 2 || discussed succession arrangements, and suggested Plaintiffs’ ages made them “incapable 3 a ‘modern approach’ because they were ‘at the age of 64/65.’” Id. at 931. 4 On or about May 21, 2018, Defendant sent letters to Plaintiffs informing them their 5 ||rolling five-year employment terms were being converted into four- or five-year fixed 6 ||terms, such that each Plaintiff would be terminated prior to the San Diego Branch’s 7 \{closure date. Jd. ¢ 33. The required review process of Plaintiffs’ rolling terms of 8 ||employment did not occur. Id. ¥ 26. 9 Defendant also unilaterally imposed a multi-year budget that was allegedly 10 || insufficient to provide adequate funding for Plaintiffs’ research. Jd. 32. 11 On February 12, 2019, at Defendant’s request, Plaintiffs (except Plaintiff Mischel) 12 attended a meeting with Defendant’s President and CEO, Edward McDermott, and 13 ||Defendant’s Scientific Director, Dr. Chi Van Dang. Id. 99 5, 35. At the meeting, 14 || Defendant presented Plaintiffs with the same reduced budget and made receiving this 15 ||}reduced funding contingent upon Plaintiffs executing a Transition Agreement and 16 || Release (“Transition Agreement’). Jd. 4 36. 17 The Transition Agreement required Plaintiffs to diligently pursue their scientific 18 ||research as Defendant’s employees despite the cut in research funding. /d. 437. The 19 || Transition Agreement also included a unilateral release and non-disparagement clause 20 |/and obligated Plaintiffs to ensure Defendant continued to recetve UCSD’s cooperation. 21 ||/d. At the meeting, McDermott allegedly threatened “consequences” if Plaintiffs did not 22 |/sign the Transition Agreement. /d. 4.5. None of the Plaintiffs agreed to the Transition 23 || Agreement’s terms. Jd. at □ 39. 24 After they declined to sign the Transition Agreement, Plaintiffs allege Defendant 25 ||followed through on its threats and retaliated by further cutting Plaintiffs’ research 26 || budgets for 2020 and 2021. Jd. 441. Beginning July 1, 2019, Defendant also refused to 27 || pay cost of living and merit increases to match the UCSD salary scale. Id. 4 42. 28

On October 31, 2019, Plaintiff Kolodner wrote a letter to McDermott, Notter, and 2 || John Gordon, the Chair of Defendant’s Audit Committee, providing an analysis of why 3 2020-2021 budget was allegedly insufficient to meet Defendant’s legal obligations. 4 || Id. § 43. Kolodner was demoted four days later. Jd. 5 On November 4, 2019, and November 15, 2019, Plaintiffs were told Defendant would 6 ||not fund any research starting in 2020. /d. 4] 44.

Free access — add to your briefcase to read the full text and ask questions with AI

Cleveland v. Ludwig Institute for Cancer Research Ltd., (S.D. Cal. 2022).

Cleveland v. Ludwig Institute for Cancer Research Ltd. (Cleveland v. Ludwig Institute for Cancer Research Ltd.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Parklane Hosiery Co. v. Shore
439 U.S. 322 (Supreme Court, 1979)
New Hampshire v. Maine
532 U.S. 742 (Supreme Court, 2001)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Jackson v. Bank of Hawaii
902 F.2d 1385 (Ninth Circuit, 1990)
United States v. John Jacob Sanchez
24 F.3d 1259 (Tenth Circuit, 1994)
Pardo v. Olson & Sons, Inc.
40 F.3d 1063 (Ninth Circuit, 1994)
Thompson v. Davis
295 F.3d 890 (Ninth Circuit, 2002)
Manzarek v. St. Paul Fire & Marine Insurance
519 F.3d 1025 (Ninth Circuit, 2008)
Patten v. Grant Joint Union High School District
37 Cal. Rptr. 3d 113 (California Court of Appeal, 2005)
Sandell v. Taylor-Listug, Inc.
188 Cal. App. 4th 297 (California Court of Appeal, 2010)
Eckert Cold Storage, Inc. v. Behl
943 F. Supp. 1230 (E.D. California, 1996)
United States v. Petraia Maritime Ltd.
489 F. Supp. 2d 90 (D. Maine, 2007)
Guz v. Bechtel National, Inc.
8 P.3d 1089 (California Supreme Court, 2000)
Hager v. County of Los Angeles CA2/3
228 Cal. App. 4th 1538 (California Court of Appeal, 2014)